Acquired resistance to immunotherapy and future challenges.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26822578.
- Also identified by DOI 10.1038/nrc.2016.2 and PMC identifier 6330026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Advances in immunotherapy have resulted in remarkable clinical responses in some patients. However, one of the biggest challenges in cancer therapeutics is the development of resistant disease and disease progression on or after therapy. Given that many patients have now received various types of immunotherapy, we asked three scientists to give their views on the current evidence for whether acquired resistance to immunotherapy exists in patients and the future challenges posed by immunotherapy.
Medical subject headings
- Immunotherapy
- Neoplasms